相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pathways of Antigen Processing
Janice S. Blum et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
A Review of Preventative Methods against Human Leishmaniasis Infection
Lisa Stockdale et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Therapeutic Vaccination With Recombinant Adenovirus Reduces Splenic Parasite Burden in Experimental Visceral Leishmaniasis
Asher Maroof et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Jorge Alvar et al.
PLOS ONE (2012)
The development and clinical evaluation of second-generation leishmaniasis vaccines
Malcolm S. Duthie et al.
VACCINE (2012)
Vaccines for canine leishmaniasis
Clarisa B. Palatnik-de-Sousa
FRONTIERS IN IMMUNOLOGY (2012)
Development of Vaccines against Visceral Leishmaniasis
Krystal J. Evans et al.
JOURNAL OF TROPICAL MEDICINE (2012)
Clinical Applications of DNA Vaccines: Current Progress
Bernadette Ferraro et al.
CLINICAL INFECTIOUS DISEASES (2011)
Visceral leishmaniasis: immunology and prospects for a vaccine
P. M. Kaye et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Leishmaniasis chemotherapy-challenges and opportunities
S. L. Croft et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Leishmaniasis: complexity at the host-pathogen interface
Paul Kaye et al.
NATURE REVIEWS MICROBIOLOGY (2011)
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis
Jaya Chakravarty et al.
VACCINE (2011)
Vaccines for the Leishmaniases: Proposals for a Research Agenda
Carlos Henrique Nery Costa et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Incidence of Symptomatic and Asymptomatic Leishmania donovani Infections in High-Endemic Foci in India and Nepal: A Prospective Study
Bart Ostyn et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injection
Florence Faurez et al.
VACCINE (2010)
KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major
Suniti Bhaumik et al.
VACCINE (2009)
DNA vaccines: ready for prime time?
Michele A. Kutzler et al.
NATURE REVIEWS GENETICS (2008)
First generation leishmaniasis vaccines: A review of field efficacy trials
Sassan Noazin et al.
VACCINE (2008)
HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages
Rajatava Basu et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Balancing immunity and pathology in visceral leishmaniasis
Amanda C. Stanley et al.
IMMUNOLOGY AND CELL BIOLOGY (2007)
Approaches for the identification of potential excreted/secreted proteins of Leishmania major parasites
M Chenik et al.
PARASITOLOGY (2006)
Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis
S Rafati et al.
VACCINE (2006)
Leishmanization: Use of an old method for evaluation of candidate vaccines against leishmaniasis
A Khamesipour et al.
VACCINE (2005)
DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice
L López-Fuertes et al.
VACCINE (2002)
Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections
A Ghosh et al.
VACCINE (2001)
分享论文
